Belviq
Belviq
Belviq (pronounced: bel-VEEK) is a weight-loss drug developed by Arena Pharmaceuticals. It is chemically known as lorcaserin hydrochloride.
Etymology
The name "Belviq" is a brand name, likely derived from a combination of words or ideas that suggest weight loss or health. The exact etymology is not publicly known as it is a proprietary name created by the pharmaceutical company.
Usage
Belviq is used together with diet and physical exercise to treat obesity. It is sometimes given to people who have obesity-related health problems such as high blood pressure, high cholesterol, or type 2 diabetes. Belviq works by controlling appetite — specifically by activating brain receptors for serotonin, a neurotransmitter that triggers feelings of satiety and satisfaction.
Side Effects
Common side effects of Belviq include headache, dizziness, fatigue, nausea, dry mouth, and constipation. In some cases, it can cause serious side effects like serotonin syndrome, particularly when taken with certain medicines that increase serotonin levels or activate serotonin receptors.
Withdrawn from the US market
On 17 September 2020, the US FDA withdrew approval for lorcaserin and for extended-release lorcaserin tablets
Related Terms
- Obesity: A disorder involving excessive body fat that increases the risk of health problems.
- Serotonin: A neurotransmitter that sends signals between your nerve cells.
- Serotonin Syndrome: A group of symptoms that may occur with the use of certain serotonergic medications or drugs.
- Type 2 Diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
See Also
- Phentermine: Another type of weight-loss medication.* Orlistat: A medication used to aid in weight loss.
External links
- Medical encyclopedia article on Belviq
- Wikipedia's article - Belviq
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski